Clinical Trial 48338

Las Vegas, NV 89106


Atopic Dermatitis (Eczema) - Las Vegas NV
Click image to enlarge

Galderma is conducting a study of an investigational drug called nemolizumab for the treatment of Atopic Dermatitis/Eczema.  The goal of the study is to evaluate the immune response to vaccinations for patients receiving the study drug.

  • Be 12-54 years old
  • Have had Atopic Dermatitis/Eczema for at least 2 years
  • Have Atopic Dermatitis/Eczema that covers at least 10% of your body 
  • Have used another Eczema treatment or cream in the last 6 months that didn’t fully treat your Eczema
  • Be willing to receive two common approved vaccinations during study participation
  • Subject willing to undergo treatment for 16 weeks

Qualified Participants May Receive:

Participants will receive all study-related visits, tests, common approved vaccines, and study drug or a placebo from a dedicated medical team at no cost. Volunteers who qualify to take part in the study will receive compensation for study-related travel.

Clinical trials are medical research studies designed to test the safety and/or effectiveness of new investigational drugs, devices, or treatments in humans. These studies are conducted worldwide for a range of conditions and illnesses. Learn more about clinical research and participating in a study at About Clinical Trials.